Elite in Collagenous Colitis

Stephan Miehlke

Hamburg, HH, DE 
Elite in Collagenous Colitis
Hamburg, HH, DE 
OverviewLocationsClinical Research

Overview

Stephan Miehlke practices in Hamburg, Germany. Mr. Miehlke is rated as an Elite expert by MediFind in the treatment of Collagenous Colitis. His top areas of expertise are Lymphocytic Colitis, Collagenous Colitis, Esophagitis, Endoscopy, and Colonoscopy.

His clinical research consists of co-authoring 82 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles in the study of Collagenous Colitis.

Gender
Male

Locations

Hamburg, HH, Germany
Other Locations
Eppendorf, HH, Germany
Dresden, SN, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective Randomized Comparison of the Adenoma Detection Rate in Screening Colonoscopy With and Without a Disposable Cap (ENDOCUFF VISION®)
A Prospective Randomized Comparison of the Adenoma Detection Rate in Screening Colonoscopy With and Without a Disposable Cap (ENDOCUFF VISION®)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Procedure
Randomised, Double-blind, Placebo-controlled, Multi-centre Trial on the Efficacy and Safety of Budesonide for Induction of Remission in Incomplete Microscopic Colitis
Randomised, Double-blind, Placebo-controlled, Multi-centre Trial on the Efficacy and Safety of Budesonide for Induction of Remission in Incomplete Microscopic Colitis
Enrollment Status: Completed
Publish Date: July 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Study on the Efficacy and Tolerability of a 8-week Treatment With Budesonide vs. Mesalazine vs. Placebo in Patients With Lymphocytic Colitis
Double-blind, Double-dummy, Randomised, Placebo-controlled, Multi-centre Phase III Study on the Efficacy and Tolerability of a 8-week Treatment With Budesonide vs. Mesalazine vs. Placebo in Patients With Lymphocytic Colitis
Enrollment Status: Completed
Publish Date: July 26, 2017
Intervention Type: Other, Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

82 Total Publications

Development and Validation of a Novel patient-reported Outcome for Microscopic Colitis-Microscopic Colitis Score (MCS).
Development and Validation of a Novel patient-reported Outcome for Microscopic Colitis-Microscopic Colitis Score (MCS).
Journal: Journal of Crohn's & colitis
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Miehlke's expertise for a condition
ConditionClose
View All 12 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile